Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine and CDP-choline in Schizophrenia
NCT00509067Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Nov 2007
- Primary completion
- Mar 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of galantamine, citicoline in schizophrenia, sponsored by Georgetown University. Started Nov 2007; status: completed.
02
Drugs
galantamineciticoline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00509067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509067.